FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/05/042522 [Registered on: 12/05/2022] Trial Registered Prospectively
Last Modified On: 06/05/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Clinical Study on Bronchial asthma. 
Scientific Title of Study   The Efficacy of Homoeopathic Simillimum in treating Atopic Bronchial Asthma With an Evaluation based on Serum IgE. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Y Araafath 
Designation  PG Scholar 
Affiliation  Vinayaka Mission Homoeopathic Medical College and Hospital 
Address  Department of Organon of Medicine Opd Room no 2e1 Vinayaka Mission Homoeopathic Medical College and Hospital NH47 Sankari Main road Seeragapadi Salem Tamilnadu 636308 India

Salem
TAMIL NADU
636308
India 
Phone  8610229276  
Fax    
Email  dr.araafath97@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr E Nisha Paul 
Designation  Professor and Head of Department 
Affiliation  Vinayaka Mission Homoeopathic Medical College and Hospital 
Address  Department of Organon of Medicine Opd Room no 2e1 Vinayaka Mission Homoeopathic Medical College and Hospital NH47 Sankari Main road Seeragapadi Salem Tamilnadu 636308 India

Salem
TAMIL NADU
636308
India 
Phone  9995680275  
Fax    
Email  Nisha.gopal2012@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr E Nisha Paul 
Designation  Professor and Head of Department 
Affiliation  Vinayaka Mission Homoeopathic Medical College and Hospital 
Address  Department of Organon of Medicine Opd Room no 2e1 Vinayaka Mission Homoeopathic Medical College and Hospital NH47 Sankari Main road Seeragapadi Salem Tamilnadu 636308 India

Salem
TAMIL NADU
636308
India 
Phone  9995680275  
Fax    
Email  Nisha.gopal2012@gmail.com  
 
Source of Monetary or Material Support  
Vinayaka Mission Homoeopathic Medical College and Hospital NH47 Sankari Main road Seeragapadi Salem Tamilnadu 
 
Primary Sponsor  
Name  Vinayaka Mission Homeopathic Medical College and Hospital 
Address  NH47 Sankari Main road Seeragapadi Salem Tamilnadu 636308 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr E Nisha Paul  Vinayaka Mission Homoeopathic Medical College and Hospital  Department of Organon of Medicine Opd Room no 2e1 Vinayaka Mission Homoeopathic Medical College and Hospital NH47 Sankari Main road Seeragapadi Salem Tamilnadu 636308
Salem
TAMIL NADU 
9995680275

Nisha.gopal2012@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Commitee Vinayaka Mission Kirupananda Variyar Medical College and Hospital Salem  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J459||Other and unspecified asthma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic Medicine  Homoeopathic Medicines are selected on basis of Symptom similarity The Dose is selected based upon individualization and susceptibility of the patient The Medicine is administered via orally and followup is taken in every 15 days and Maximum period of study is 6 months 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient selected from age 5 to 60 and patients with clinical presentation of Bronchial asthma and Patients with strong family history and previous atopic History 
 
ExclusionCriteria 
Details  Patients suffering from other respiratory diseases
Patients suffering from other systemic diseases
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Serum IgE  after 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
It is expected that the proposed study will be useful in reducing the symptoms of Bronchial asthma and to improve the quality of life of the patients.  After 6 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   16/05/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Bronchial asthma is characterized by chronic airway inflammation and increased airway responsiveness leading to symptoms of wheeze, cough and dyspnea. The prevalence of asthma is increasing steadily. Asthma ranks amongst the most common chronic ailments of the globe. It is estimated that 300 million people worldwide suffer from asthma. Annually 250,000 deaths are attributed to asthma, and its complications. In our country, the disease is under recognized and underrated. The WHO estimates that asthma contributes to the loss of 15 million disability-adjusted life years.

              The prevalence of asthma has increased markedly over the past 30 years. In developed countries, approximately 10% of adults and 15% of children have asthma. The majority of asthmatics have childhood onset of disease. Asthma often starts early in life. The prevalence of asthma is increasing in all age group, despite major advances in understanding the etiology and pathophysiology of asthma and development of new therapeutic modalities to control symptoms and prevent exacerbations, effective therapies are not widely used.

    Homoeopathy has a vital role in the treatment of asthma. . Hence, I selected the topic “THE EFFICACY OF HOMEOPATHIC SIMILLIMUM ON TREATING ATOPIC BRONCHIAL ASTHMA WITH AN EVALUATION BASED ON SERUM  IgE”
 
Close